Paysign, Inc. (NASDAQ:PAYS) CFO Sells $215,507.64 in Stock

Key Points

• Paysign, Inc. CFO Jeffery Bradford Baker sold 30,396 shares of the company for approximately $215,507.64, resulting in a 10.75% decrease in his ownership.
• The company's stock price reached $7.16 after gaining $0.02 during trading, with a market cap of $388.22 million and a price-to-earnings ratio of 65.10.
• Paysign reported a $0.05 EPS for the last quarter, exceeding expectations, alongside revenue of $18.60 million, higher than the forecast of $17.49 million.

Paysign, Inc. (NASDAQ:PAYS - Get Free Report) CFO Jeffery Bradford Baker sold 30,396 shares of the firm's stock in a transaction on Monday, August 4th. The shares were sold at an average price of $7.09, for a total transaction of $215,507.64. Following the transaction, the chief financial officer owned 252,273 shares in the company, valued at $1,788,615.57. This represents a 10.75% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Paysign Trading Down 6.2%

PAYS traded down $0.37 during trading on Friday, hitting $5.53. The stock had a trading volume of 662,172 shares, compared to its average volume of 492,824. The firm has a market cap of $300.00 million, a PE ratio of 46.21 and a beta of 0.78. Paysign, Inc. has a 12 month low of $1.80 and a 12 month high of $8.88. The company has a 50 day simple moving average of $6.64 and a 200-day simple moving average of $4.01.

Paysign (NASDAQ:PAYS - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.02 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.02). The firm had revenue of $19.08 million during the quarter, compared to the consensus estimate of $18.69 million. Paysign had a return on equity of 20.72% and a net margin of 9.90%. As a group, sell-side analysts anticipate that Paysign, Inc. will post 0.21 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on PAYS shares. LADENBURG THALM/SH SH raised their price target on shares of Paysign from $7.25 to $8.25 and gave the company a "buy" rating in a report on Friday, May 9th. Lake Street Capital raised their price target on shares of Paysign from $9.00 to $10.00 and gave the company a "buy" rating in a report on Wednesday. Finally, DA Davidson set a $9.00 price target on shares of Paysign in a report on Thursday.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of PAYS. Two Sigma Investments LP grew its position in Paysign by 98.8% in the 4th quarter. Two Sigma Investments LP now owns 181,775 shares of the company's stock worth $549,000 after purchasing an additional 90,346 shares during the last quarter. Millennium Management LLC grew its position in Paysign by 123.6% in the 4th quarter. Millennium Management LLC now owns 325,334 shares of the company's stock worth $983,000 after purchasing an additional 179,814 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Paysign by 51.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 267,899 shares of the company's stock worth $809,000 after purchasing an additional 90,702 shares during the last quarter. GSA Capital Partners LLP grew its position in Paysign by 38.3% in the 1st quarter. GSA Capital Partners LLP now owns 271,781 shares of the company's stock worth $576,000 after purchasing an additional 75,311 shares during the last quarter. Finally, Renaissance Technologies LLC grew its position in Paysign by 11.0% in the 4th quarter. Renaissance Technologies LLC now owns 1,501,622 shares of the company's stock worth $4,535,000 after purchasing an additional 149,200 shares during the last quarter. Institutional investors own 25.89% of the company's stock.

Paysign Company Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.